Discover the technologies transforming the future of clinical research, from AI and decentralized clinical trials to ...
The U.S. Multiplex Assays Market is projected to grow from USD 1.12 Billion in 2025 to USD 2.65 Billion by 2035, while Europe ...
A month long expedition underway in the Cook Islands is looking to further understand how climate change affects the ocean.
The following article is an opinion piece written by Rosa Sottile, PhD. The views and opinions expressed in this article are those of the author and do not necessarily reflect the official position of ...
New 7-Laser Cytek Borealis™ System With Deep Ultraviolet and Infrared cFluor® Reagents; Cytek Aurora™ Evo System Enhancements for Automation and Workflow Efficiency Cytek Borealis™ Full Spectrum Flow ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CEO Danieli said, "the new 2026 CMS fee schedule was released and it included a reduction of 8% in the fee for one of our most frequently used tests, flow cytometry. Subsequently, we had to write down ...
Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, making it fundamental to medical research. As assays evolve to capture more ...
Cleaning blood from a violent crime scene can complicate crime scene investigations, particularly when accurate evidence is required for a conviction in court. A new study led by Flinders University, ...
The FDA issued draft guidance in January 2026 endorsing MRD as a primary endpoint in multiple myeloma drug trials. Credit: luchschenF / Shutterstock.com. Quest Diagnostics has introduced a new flow ...
Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. Quest Flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results